Pharmalicensing

Innovaro Pharmalicensing

Innovaro Pharmalicensing is the leading global resource for partnering, licensing, and business development within the life science and biopharmaceutical industries. Our unique services complement and enhance business development activity throughout the deal-making process-from finding the perfect partner to closing the deal.
Don’t hesitate to take a look. With more than fourteen years dedicated to building relationships and facilitating successful partnerships, Innovaro Pharmalicensing provides the online connection across all aspects of life science between companies, research laboratories and universities.

Overview

"Pharmalicensing is an elegant way of getting in touch with partners. Pharmalicensing is different to other services in that it is more active. Many partnering companies are just databases, but Pharmalicensing offers that additional level of personal service."

- Mr. Rene van der Linden, Partner at Middendium Life Sciences and former Director of Business Development at Pantarhei Bioscience BV, Netherlands.

We offer a range of services to complement your existing business, from intelligence reports through full consultancy services.

Innovaro Pharmalicensing affords clients the ability to in-license and out-license intellectual property and provides partnering services, business development reports and industry news. We track more than 200,000 visitors per month and continue to drive key partnerships with other value-added sites to help drive additional traffic.

More than half of the Innovaro Pharmalicensing audience is made up of the industry's most senior decision makers, CEOs, Chairman, VPs, Licensing and Business Development Managers - ensuring that the right people are looking at your opportunities.

By bringing buyers and sellers together we provide the most extensive and well-trafficked marketplace and provide the means to market external ideas, technologies and capabilities with the use of a complete suite of tools to research, locate and monitor select technologies.

Partnering Search

Based on your company's brief we will search for partners for you and provide a qualified target list of companies. Your best prospects, we like to call them. Then on your instruction we will contact those target companies on your behalf to spearhead introductions and coordinate initial contacts and conference calls. Your hot list.

  • Maximize your potential for finding the most suitable partner
  • Utilize the knowledge and expertise of our dedicated Innovaro Pharmalicensing team
  • Complement your existing business development activities


 

Licensing Opportunities in Life Sciences

Innovaro Pharma Transfer is widely recognized as the most comprehensive source of research and business development opportunities for the international pharmaceutical market. Hundreds of new opportunities are added every week that are specifically matched to the needs of our subscribers.

Delivering Concise Abstracts Summarizing Innovations Within Developing Pharma Research.
Our opportunities come directly from pharmaceutical and biotechnology companies, government agencies, research institutes and academia encompassing all areas of pipeline development, from early-stage discovery, through preclinical and clinical trials, to registered products. All opportunities are available for co-development or licensing.

Our goal is to become an extension of your business development department by continually sourcing opportunities that directly match your company’s specific needs.

Since conception in 1998, we have grown to publish approximately 11,000 opportunities each year, with over 5,000 being brand new opportunities. The opportunities are actively sourced and updated on a daily basis, providing a constant stream of new licensing opportunities of 100 per week, 20 per day.

We bring you the advantage of a reliable, robust and comprehensive service so you can make accurate decisions based on relevant industry data, and do it fast. You benefit from Pharma Transfer's consultative approach that meets the need for research on new pharmacological compounds and enabling technologies available for licensing or partnering.